Roser Vives Dilme
Hospital Clínico San Carlos, Universidad Complutense de Madrid
Papers
3
Total Citations
16
H-Index
2
About
Dr. Roser Vives Dilme is a leading urologic oncologist whose research focuses on improving surgical and prognostic outcomes for prostate cancer, particularly through the lens of robot-assisted radical prostatectomy (RARP). Her work has made significant contributions to understanding how unconventional tumor histology and preoperative biomarkers influence patient prognosis. In a landmark 2024 international multicenter study, Dr. Vives Dilme demonstrated the critical oncological and functional prognostic value of unconventional prostate cancer histology in localized disease treated with RARP, providing surgeons with vital preoperative insights. Her research further established the importance of PSA density as a powerful preoperative predictive factor for oncological outcomes, helping to refine patient risk stratification. Dr. Vives Dilme has also explored the integration of novel technologies—such as advanced imaging and intraoperative navigation—into the RARP procedure, showing their potential to enhance surgical planning, precision, and patient education. With her work accumulating citations and shaping clinical practice, Dr. Vives Dilme stands at the forefront of efforts to personalize and optimize surgical treatment for prostate cancer patients.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3